Literature DB >> 15536258

Cytochrome P450c17alpha 5'-untranslated region *T/C polymorphism in endometriosis.

Yao-Yuan Hsieh1, Chi-Chen Chang, Fuu-Jen Tsai, Cheng-Chieh Lin, Chang-Hai Tsai.   

Abstract

Estrogen plays a role in the pathogenesis of endometriosis. The CYP17 gene codes for the cytochrome P450c17alpha enzyme that is involved in the estrogen biosynthesis. We aimed to investigate if CYP17 polymorphism could be used as marker to predict the susceptibility of endometriosis. Women were divided into two groups: (1) severe endometriosis (n=119); (2) non-endometriosis groups (n=128). A 169-bp fragment encompassing the T/C polymorphic site in 5'-untranslated promoter region (5'-UTR) of the CYP17 was amplified by the polymerase chain reaction, treated with restriction enzyme MspA1I, and electrophoresis. The polymorphism was divided into restriction-enzyme indigestible (T homozygote), T/C heterozygote, and digestible (C homozygote). Genotypes and allelic frequencies for this polymorphism in both groups were compared. We observed a higher but non-significant percentage of T homozygote in the endometriosis women compared with the non-endometriosis women. Proportions of T homozygote / heterozygote / C homozygote for CYP17 in both groups were: (1) 26.1/46.2/27.7% and (2) 17.2/45.3/37.5% (p-value=0.131). T allele was related with higher susceptibility of endometriosis. T and C allele frequencies in both groups were: (1) 49.2/50.8%; (2) 39.8/60.2% (p-value=0.046). Despite the CYP17* T allele appearing to be associated with a trend of increased risk of endometriosis, CYP17 5'-UTR gene polymorphism might not be a useful marker for prediction of endometriosis susceptibility.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15536258     DOI: 10.1007/bf02729896

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  24 in total

1.  Androgen receptor trinucleotide polymorphism in endometriosis.

Authors:  Y Y Hsieh; C C Chang; F J Tsai; J Y Wu; C H Tsai; H D Tsai
Journal:  Fertil Steril       Date:  2001-08       Impact factor: 7.329

2.  A polymorphism in CYP17 and endometrial cancer risk.

Authors:  C A Haiman; S E Hankinson; G A Colditz; D J Hunter; I De Vivo
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

3.  p21 gene codon 31 arginine/serine polymorphism: non-association with endometriosis.

Authors:  Y Y Hsieh; F J Tsai; C C Chang; W C Chen; C H Tsai; H D Tsai; C C Lin
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

4.  Association between CYP17 polymorphisms and the development of breast cancer.

Authors:  K J Helzlsouer; H Y Huang; P T Strickland; S Hoffman; A J Alberg; G W Comstock; D A Bell
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-10       Impact factor: 4.254

5.  Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations.

Authors:  H S Feigelson; L S Shames; M C Pike; G A Coetzee; F Z Stanczyk; B E Henderson
Journal:  Cancer Res       Date:  1998-02-15       Impact factor: 12.701

6.  Polymorphisms for interleukin-4 (IL-4) -590 promoter, IL-4 intron3, and tumor necrosis factor alpha -308 promoter: non-association with endometriosis.

Authors:  Yao-Yuan Hsieh; Chi-Chen Chang; Fuu-Jen Tsai; Yuan Hsu; Horng-Der Tsai; Chang-Hai Tsai
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

7.  Polymorphism T-->C (-34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome.

Authors:  E Diamanti-Kandarakis; M I Bartzis; E D Zapanti; G G Spina; F A Filandra; T C Tsianateli; A T Bergiele; C R Kouli
Journal:  Fertil Steril       Date:  1999-03       Impact factor: 7.329

8.  Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17.

Authors:  A H Carey; D Waterworth; K Patel; D White; J Little; P Novelli; S Franks; R Williamson
Journal:  Hum Mol Genet       Date:  1994-10       Impact factor: 6.150

9.  A polymorphism in the CYP17 gene is associated with male breast cancer.

Authors:  I E Young; K M Kurian; C Annink; I H Kunkler; V A Anderson; B B Cohen; M L Hooper; A H Wyllie; C M Steel
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

10.  No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer.

Authors:  A M Dunning; C S Healey; P D Pharoah; N A Foster; J M Lipscombe; K L Redman; D F Easton; N E Day; B A Ponder
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more
  4 in total

1.  Common Variation in the CYP17A1 and IFIT1 Genes on Chromosome 10 Does Not Contribute to the Risk of Endometriosis.

Authors:  Zhen Zhen Zhao; Dale R Nyholt; Lien Le; Susan A Treloar; Grant W Montgomery
Journal:  Open Reprod Sci J       Date:  2008-01-01

Review 2.  Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis.

Authors:  C B Tempfer; M Simoni; B Destenaves; B C J M Fauser
Journal:  Hum Reprod Update       Date:  2008-09-19       Impact factor: 15.610

3.  CYP17A1 rs743572 polymorphism might contribute to endometriosis susceptibility: evidences from a case-control study.

Authors:  Lili Cong; Qiang Fu; Tianming Gao
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

Review 4.  Genetic Characterization of Endometriosis Patients: Review of the Literature and a Prospective Cohort Study on a Mediterranean Population.

Authors:  Stefano Angioni; Maurizio Nicola D'Alterio; Alessandra Coiana; Franco Anni; Stefano Gessa; Danilo Deiana
Journal:  Int J Mol Sci       Date:  2020-03-04       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.